Wesfarmers SOAR Analysis

Wesfarmers SOAR Analysis

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Wesfarmers Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Explore the Complete Growth Strategy Behind the Preview

This Wesfarmers SOAR Analysis gives you a clear, structured view of the company's strengths, opportunities, aspirations, and results for strategy, investing, or research. What you see on this page is a real preview of the actual deliverable, so you can review the content before buying. Purchase the full version to get the complete ready-to-use analysis.

Strengths

Icon

Domination of high-barrier hardware through Bunnings

Bunnings gives Wesfarmers a rare moat in high-barrier hardware, with about 50% share of the Australian DIY and trade market. In FY2025, Bunnings delivered $18.5 billion in sales and kept returns on capital above 60%. Its prime store network and low-cost model make it hard for smaller rivals like Mitre 10 to match at scale.

Icon

Industry-leading sourcing through the Anko global brand

Kmart Australia's Anko gives Wesfarmers tight control over design, sourcing, and pricing, much like IKEA in home goods. That vertical model supported Kmart Group earnings of $683 million in the December 2025 half-year, even with sharp value pricing.

Anko now scales beyond Australia, so Wesfarmers relies less on third-party intermediaries and keeps more margin in-house.

Explore a Preview
Icon

Integrated mineral production at Mt Holland

Wesfarmers holds a 50% stake in Covalent Lithium, giving it direct exposure to Mt Holland's integrated mine-to-refinery platform. In July 2025, the Kwinana refinery produced first battery-grade lithium hydroxide, proving end-to-end supply from mine to chemical output. That internal chain lowers feedstock risk and supports supply into the fast-growing Asia-Pacific EV battery market.

Icon

Scale and data leverage through the OnePass ecosystem

OneDigital gives Wesfarmers a scale edge by linking customer data across Bunnings, Kmart, and Officeworks. OnePass boosts repeat shopping and basket size, with over 100 million annual customer interactions flowing through the ecosystem as of early 2026.

That shared data pool supports sharper retail media targeting and better demand forecasts, which can lift margins versus rivals with fragmented customer data.

Icon

A resilient, investment-grade balance sheet

Wesfarmers' investment-grade balance sheet gives it room to recycle capital into higher-growth areas like health and lithium, even in high inflation. In fiscal 2025, it reported statutory net profit after tax of $2.93 billion and kept leverage disciplined while supporting dividends. That strength also helped fund more than $1.1 billion in annual capital expenditure for store, supply chain, and platform upgrades.

Icon

Wesfarmers' Moat: Bunnings, Kmart and Capital Strength Drive Growth

Wesfarmers' biggest strength is Bunnings, which held about 50% of the Australian DIY and trade market and generated $18.5 billion in FY2025 sales with returns on capital above 60%.

Kmart Australia's Anko model keeps design, sourcing, and pricing under tight control, helping deliver $683 million in earnings in the December 2025 half-year.

A disciplined balance sheet, plus OneDigital data links and the Covalent Lithium stake, gives Wesfarmers capital, scale, and supply-chain control that rivals struggle to match.

What is included in the product

Word Icon Detailed Word Document
Provides a clear SOAR framework for analyzing Wesfarmers's strategic growth outlook
Plus Icon
Excel Icon Editable Excel File
Helps simplify Wesfarmers strategic planning by quickly highlighting strengths, opportunities, aspirations, and results in one clear view.

Opportunities

Icon

Expansion into specialized healthcare services

Expansion into specialized healthcare services gives Wesfarmers access to a $12 billion-plus Australian market as it brings together Australian Pharmaceutical Industries and SILK Laser. The group is lifting banner count to over 470 Priceline pharmacies, which helps it reach older customers as demand rises with an aging population. By adding medical aesthetics and digital scripts through InstantScripts, Wesfarmers can move more sales into higher-margin essential care.

Icon

Commercial and pro-market share gains at Bunnings

In FY2025, Bunnings still had room to lift pro-market sales, with the commercial channel estimated at about 20% share. Bunnings Trade hubs can win more recurring work from trades, while repair and maintenance demand is less tied to mortgage-rate swings than new DIY starts. That gives Wesfarmers a low-risk path to grow sales inside its existing store base.

Explore a Preview
Icon

Industrial decarbonization and green energy products

WesCEF is well placed to benefit from Western Australia's shift to hydrogen and low-carbon farming, because its chemicals, energy and fertilizers base already serves heavy industry and agriculture. In FY2025, Wesfarmers' diversified platform gives it scale to fund trials in hydrogen blending and carbon-capture pilots, both key steps in cutting emissions from industrial fuel use. The bigger upside is export: lower-emission fertilizer know-how can be sold into Asia, where tighter rules are expected by 2030.

Icon

Global expansion of the Kmart value proposition

Anko gives Wesfarmers a scalable export model: instead of funding new stores, it can license designs and ranges to overseas retailers and earn royalty income. That matters because the Kmart value proposition is already proven in Australia and New Zealand, so the next step is low-capital growth in North America and Southeast Asia. If the model keeps widening, Wesfarmers can lift high-margin earnings while diversifying away from a single-region retail base.

Icon

Optimization of last-mile logistics networks

Wesfarmers can turn Kmart and Target warehouse capacity into a store-as-hub network, using major suburban sites as local delivery nodes for faster omnichannel fulfilment. This cuts the last mile on big-box items and helps it compete with Amazon in dense areas like Sydney and Melbourne. Faster delivery windows can lift conversion, lower shipping cost per order, and make the integrated retail base more productive.

Icon

Wesfarmers' Next Growth Engines: Healthcare, Trade, Anko and Decarbonisation

Wesfarmers can grow faster in healthcare, with FY2025 sales from a national pharmacy and digital-care platform tied to an Australian market worth over A$12 billion. Bunnings Trade can win more recurring pro work, while Kmart's Anko gives low-capital export growth. WesCEF also has upside from lower-emission farming and industrial decarbonisation.

Opportunity FY2025 signal
Healthcare A$12bn+ market
Bunnings Trade ~20% commercial share

Full Version Awaits
Wesfarmers Reference Sources

You're previewing the actual Wesfarmers SOAR Analysis document, not a sample. The content shown here is taken directly from the full report you'll receive after purchase. Once checkout is complete, you'll unlock the complete, detailed, and ready-to-use version.

Explore a Preview

Aspirations

Icon

Becoming the leading health and wellness platform

Wesfarmers wants Wesfarmers Health to move beyond a pharmacy banner and become a full care platform tied into Australia's medical system. The goal is to reach 500,000 active digital users through deals that link stores, prescriptions, and telehealth. By early 2026, the unit is expected to contribute 10% of group earnings, making it a fourth pillar for Wesfarmers.

Icon

Operational excellence through AI-led productivity

Wesfarmers is pushing AI-led productivity across the supply chain, using predictive analytics and warehouse automation to cut cost-to-serve by 50-100 bps over the medium term. This matters as FY2025 domestic labor and energy costs stayed sticky, pressuring retail margins.

By 2026, management wants autonomous replenishment to be a market lead in Australia, reducing stock-outs in peak seasonal periods. The pay-off should be faster inventory turns, better availability, and less manual handling across a large store network.

Explore a Preview
Icon

Net-zero carbon footprint by 2030 for industrial operations

Wesfarmers Chemical, Energy and Fertilisers has set a clear 2030 net-zero target for Scope 1 and 2 emissions, making industrial decarbonisation a core growth lever, not just compliance. The shift to renewable power PPAs and hydrogen use should lower carbon intensity and support a premium position in green chemicals as buyers tighten supply-chain standards. For Wesfarmers, this is a strategic bet on cleaner output, stronger pricing power, and lower long-term carbon risk.

Icon

Redefining the department store through Kmart/Target synergy

Wesfarmers' goal is to finish turning Target into a premium-value chain that lifts household-ticket sales, while Kmart stays the mass-market engine. The shared low-overhead model lets the Kmart Group keep costs tight; in FY2025, Kmart Group delivered about A$1.1bn in EBIT, showing the scale behind this twin-brand plan. The aim is higher foot traffic and bigger baskets in strong suburban centres, not brand overlap.

Icon

Building a world-class lithium chemical refinery

Covalent Lithium is shifting Wesfarmers from ore extraction to on-site conversion, aiming to turn Mount Holland's 440,000 tpa spodumene output into 50,000 tpa of battery-grade lithium hydroxide at Kwinana. That would capture more of the value-add that usually sits offshore and place Wesfarmers closer to the global EV supply chain. Getting Kwinana to full nameplate output is the key test: it shows Wesfarmers can deliver and run a large, technically complex chemical plant, not just a mine.

Icon

Wesfarmers 2025: Kmart Drives Margin Growth and Health Expansion

Wesfarmers' 2025 push is to scale Health, lift Kmart Group productivity, and widen margin from automation. The clearest 2025 anchor is Kmart Group EBIT of about A$1.1bn, showing the cash engine behind the plan.

Management also wants lower supply-chain cost, better stock flow, and greener industrial growth through Covalent Lithium and CEF decarbonisation.

FY2025 Key target
Kmart Group EBIT A$1.1bn

Results

Icon

Double-digit growth in Wesfarmers Health earnings

In the first half of fiscal year 2026, Wesfarmers Health lifted earnings 35.7%, driven by transformation work across the Priceline network. Strong demand for health and beauty products, plus new wholesale partnerships, also lifted pharmacy distribution volumes. The segment generated $62 million in EBIT, showing Wesfarmers can build scale in higher-margin health services.

Icon

Strong statutory profit expansion for FY2025

Wesfarmers lifted statutory net profit after tax to A2.93 billion in FY2025, up 14.4 percent year on year, while group revenue reached A45.7 billion. That gap between profit and a tough macro backdrop shows how well the portfolio held up. Kmart Group also benefited as value-seeking shoppers shifted to cheaper options.

The numbers back a clear value-first strategy: in high inflation, Wesfarmers still grew earnings and protected demand across key banners.

Explore a Preview
Icon

Operational launch of battery-grade lithium production

Wesfarmers reached a key milestone in July 2025 when Mt Holland-Kwinana produced its first battery-grade lithium hydroxide below initial cost estimates. The business then moved into sales in fiscal year 2026, after spodumene concentrate output reached 98,000 tonnes in the December half. Early ramp-up added about $6 million to total earnings, showing the lithium pivot is starting to pay off.

Icon

Successful integration of retail data via OnePass

In FY2025, OnePass materially improved data penetration across Wesfarmers' online retail network, lifting cross-divisional shopping and sharpening conversion in OneDigital. OnePass members generated about 2x the online transaction frequency of non-members, showing the group's shift from store-led retail to a data-driven omnichannel model.

Icon

Substantial shareholder returns via capital management

In 2025, Wesfarmers showed the strength of its capital-light model by recommending a $1.50 per share capital distribution after a surge in profit. It also declared a fully franked final dividend of $1.11 per share, lifting total dividends 4.0% year on year. The payout returned cash to more than 475,000 owners while the group kept investing in long-term growth.

Icon

Wesfarmers Posts Strong FY2025 Profit Growth

Wesfarmers delivered A2.93 billion statutory NPAT in FY2025, up 14.4 percent, on A45.7 billion revenue. Kmart-led value demand and strong Health earnings helped offset a tougher retail backdrop. The group also kept rewarding owners, lifting total dividends 4.0 percent to A1.11 per share final.

FY2025 metric Value
Statutory NPAT A2.93 billion
Revenue A45.7 billion
Final dividend A1.11 per share

Frequently Asked Questions

Wesfarmers leverages the unparalleled market share of Bunnings Warehouse, which holds approximately 50 percent of the DIY hardware sector. This dominant position is supported by a massive private-label sourcing network through the Anko brand and high-tier data analytics. These assets helped the group achieve a $2.93 billion statutory net profit in fiscal year 2025 while maintaining high returns on capital exceeding 60 percent at Bunnings.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.